Patents by Inventor Soo S. Ko

Soo S. Ko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic piperidines as modulators of chemokine receptor activity
    Patent number: 6759411
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: July 6, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040058960
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: June 19, 2003
    Publication date: March 25, 2004
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker
  • N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040058961
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: July 10, 2003
    Publication date: March 25, 2004
    Inventors: Soo S. Ko, James R. Pruitt, Dean A, Wacker, Douglas G. Batt
  • 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
    Patent number: 6706735
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: June 26, 2002
    Date of Patent: March 16, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Paul S. Watson, Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040034063
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: February 6, 2003
    Publication date: February 19, 2004
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Ui Tae Kim, Dean A. Wacker, Changsheng Zheng
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040006107
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: October 24, 2002
    Publication date: January 8, 2004
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker, Ui Tae Kim
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040002515
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: October 24, 2002
    Publication date: January 1, 2004
    Inventors: Soo S. Ko, Cheryl McArdle Clark, George V. DeLucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker
  • N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6627629
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: September 30, 2003
    Assignee: Bristol-Myers Squibb Pharma
    Inventors: Soo S. Ko, James R. Pruitt, Dean A. Wacker, Douglas G. Batt
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6605623
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: August 12, 2003
    Assignee: Bristol-Myers Squibb Pharma Co.
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker
  • 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
    Publication number: 20030144273
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: June 26, 2002
    Publication date: July 31, 2003
    Inventors: Paul S. Watson, Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20030114489
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: June 26, 2002
    Publication date: June 19, 2003
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Ui Tae Kim, Joseph B. Santella, Dean A. Wacker
  • 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolines useful as HIV reverse transcriptase inhibitors
    Publication number: 20030092722
    Abstract: The present invention relates to 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones of formula I: 1
    Type: Application
    Filed: June 11, 2002
    Publication date: May 15, 2003
    Inventors: Jeffrey W. Corbett, Soo S. Ko
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6525069
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: February 25, 2003
    Assignee: Bristol-Myers Squibb Pharma Co.
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Ui Tae Kim, Dean A. Wacker, Changsheng Zheng
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6521592
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: February 18, 2003
    Assignee: Bristol-Myers Squibb Pharma Co.
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Daniel S. Gardner
  • N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20030032654
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: June 29, 2001
    Publication date: February 13, 2003
    Inventors: Soo S. Ko, James R. Pruitt, Dean A. Wacker, Douglas G. Batt
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20030013741
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: October 23, 2001
    Publication date: January 16, 2003
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Joseph B. Santella, Daniel S. Gardner
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6492400
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: December 10, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker, Ui Tae Kim
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6486180
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: November 26, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Soo S. Ko, Cheryl McArdle Clark, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6444686
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: September 3, 2002
    Assignee: Brsitol-Myers Squibb Pharma Company
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Ui Tae Kim, Joseph B. Santella, III, Dean A. Wacker
  • Heterocyclic piperidines as modulators of chemokine receptor activity
    Publication number: 20020119980
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: October 18, 2001
    Publication date: August 29, 2002
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker